Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease

Immunology

Volumn 89, Issue 1, 1996, Pages 20-25

  Bras A ^a   Aguas A P ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 65;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; ETIOLOGY; FEMALE; HOST RESISTANCE; LIVER; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 0029814323     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-717.x     Document Type: Article

References (39)

1. BACH J.F. & LESAVRE P. (1989) Immunologie: de la biologie à la clinique. Médecine-Sciences Flammarion.
2. MAKINO S., KUNIMOTO K., MURAOKA Y. et al. (1980) Breeding of a non-obese, diabetic strain of mice. Exp Anim 29, 1.
3. HARADA M., KISHIMOTO Y. & MAKINO S. (1990) Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 8, 85.
4. SADELAIN M.W.J., QIN H.Y., LAUZON J. & SINGH B. (1990) Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39, 583.
5. QIN H.Y., SADELAIN M.W.J., HITCHON C., LAUZON J. & SINGH B (1993) Complete Freund's adjuvant-induced T-cells prevents the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 150, 2072.
6. ELIAS D., MARKOVITS D., RESHEF T., VAN DER ZEE R. & COHEN I.R. (1990) Induction and therapy of autoimmune diabetes in nonobese diabetic (NOD/Lt) mouse by a 65 KDa heat shock protein. Proc Natl Acad Sci USA 87, 1576.
7. ELIAS D., RESHEF T., BIRK O.S., VAN DER ZEE R., WALKER M.D. & COHEN I.R. (1991) Vaccination against autoimmune mouse diabetes with a T cell epitope of the human 65 KDa heat shock protein. Proc Natl Acad Sci USA 88, 3088.
8. TISCH R., YANG X.D., SINGER S.M., LIBLAU R.S., FUGGER L. & MCDEVITT H.O. (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366, 72.
9. BACH J.-F. (1993) Immunosuppressive therapy of autoimmune diseases. Immunol Today 14, 322.
10. GARCHON H.J., BEDOSSA P., ELOY L. & BACH J.-F. (1991) Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice. Nature 353, 260.
11. CORNALL R.J., PRINS J.B., TODD J.A. et al. (1991) Type 1 diabetes in mice is linked to the interleukin 1 receptor and Lsh/Ity/Bcg genes on chromosome 1. Nature 353, 262.
12. YAGI H., MATSUMOTO M., SUZUKI S. et al. (1991) Possible mechanisms of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice. Cell Immunol 138, 130.
13. YAGI H., MATSUMOTO M., KISHIMOTO Y. et al. (1991) Possible mechanisms of the preventive effect of BCG against diabetes mellitus in NOD mouse. II. Suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice. Cell Immunol 138, 142.
14. GRANGE J.M. & YATES M.D. (1986) Infections caused by opportunist mycobacteria: a review. J R Soc Med 79, 226.
15. NIGHTINGALE S.D., BYRD L.T. & SOUTHERN P.M. et al. (1992) Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 165, 1082.
16. JACOBSON M.A., HOPEWELL P.C., YAJKO M. et al. (1991) Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 164, 994.
17. BRÁS A. & ÁGUAS (1994) Protection against autoimmune diabetes by Mycobacterium avium infection in NOD mice. Abstract Book of the 12th European Meeting of Immunology, Barcelona, pp. 99, abstr. no. W12-59.
18. GROS P., SKAMENE E. & FORGET A. (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127, 2417.
19. SKAMENE E., GROS P., FORGET A. et al. (1982) Genetic regulation of resistance to intracellular pathogens. Nature 297, 506.
20. ORME I.M., STOKES R.W. & COLLINS F.M. (1986) Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun 54, 56.
21. APPELBERG R. & SARMENTO A.M. (1990) The role of macrophage avtivation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol 80, 324.
22. MALO D., VOGAN K., VIDAL S. et al. (1994) Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23, 51.
23. SILVA M.T. & MACEDO P.M. (1983) The interpretation of the ultrastructure of Mycobacterium cells in transmission electron microscopy of ultrathin sections. Int J Lepr 51, 225.
24. SILVA M.T., APPELBERG R., SILVA M.N.T. & MACEDO P.M. (1987) In vivo killing and degradation of Mycobacterium avium within mouse peritoneal macrophages. Infect Immun 55, 2006.
25. ÁGUAS A.P., ESAGUY N., SUNKEL C.E. & SILVA M.T. (1990) Crossreactivity and sequence homology between the 65-kDa mycobacterial heat shock protein and human lactoferrin, transferrin and DR subsets of MHC class II molecules. Infect Immun 58, 1461.
26. LUNDKVIST I., HOLMBERG D., IVARS F. & COUTINHO A. (1986) The immune response to bacterial dextrans. III. Ontogenic development and strain distribution of specific clonal precursors. Eur J Immunol 16, 357.
27. ESAGUY N., MACEDO P.M., CASTRO A.P. & ÁGUAS A.P. (1992) Acquisition of autoimmunity genes by New Zealand mice is associated with natural resistance to infection by mycobacteria. J Autoimm 5, 641.
28. MARTINS T.C. & ÁGUAS A.P. (1996) Changes in B and T lymphocytes associated with mycobacteria-induced protection of NOD mice from diabetes. J Autoimm (in press).
29. KAYE P.M., COOKE A., LUND T., WATTIE M. & BLACKWELL J.M. (1992) Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules. Eur J Immunol 22, 357.
30. BIRK O.S. & COHEN I.R. (1993) T-cell autoimmunity in type 1 diabetes mellitus. Curr Opin Immunol 5, 903.
31. JINDAL S., DUDANI A.K., HARLEY C.D., SINGH B. & GUPTA R.S. (1989) Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol 9, 2279.
32. VAN EDEN W., HOLOSHITZ J. & COHEN I.R. (1987) Antigenic mimicry between mycobacteria and cartilage proteoglycans: the model of adjuvant arthritis. Concepts Immunopathol 4, 144.
33. COHEN I.R. (1991) Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu Rev Immunol 9, 567.
34. ÁGUAS A.P., ESAGUY N., VAN EMBDEN J.D.A. & SILVA M.T. (1991) Autoimmune disease and leprosy: role of molecular mimicry between host and Mycobacterium leprae proteins. Health Coop Papers (Italy) 12, 87.
35. ESAGUY N., FREIRE O., VAN EMBDEN J.D.A. & ÁGUAS A.P. (1993) Lactoferrin triggers in vitro proliferation of T cells of Lewis submitted to mycobacteria-induced adjuvant arthritis. Scand J Immunol 38, 147.
36. ESAGUY N. & ÁGUAS A.P. (1996) Prevention of adjuvant arthritis in Lewis rats by neonatal bacille Calmette Guérin (BCG) infection. Clin Exp Immunol 104, 103.
37. KINGSTON A.E., HICKS C.A., COLSTON M.J. & BILLINGHAM M.E.J. (1996) A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol 103, 77.
38. RAGNO S., WINROW V.R., MASCAGNI P. et al. (1996) A synthetic 10-kD heat shock protein (hsp 10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin Exp Immunol 103, 384.
39. BAXTER A.G., HEALEY D. & COOKE A. (1994) Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity. Scand J Immunol 39, 602.